Despite the increasing number of newly identified renal neoplasms, the diagnosis of renal
cell carcinoma (RCC) can usually be reached with careful histologic examination and a …

Background Sal**ectomy is recommended as a risk-reducing strategy for epithelial tubo-
ovarian cancer. The gold standard procedure is complete tubal excision. Objective The …

Clear cell renal cell carcinomas (CCRCC) rarely metastasizes to the gynecologic tract. In
this study, we analyzed a multi-institutional data set to provide insights into the clinical …

Renal impairment is a common complication in patients with ovarian cancer. Renal
impairment in ovarian cancer patients can be caused by various factors. Many of the …

Renal cell carcinoma (RCC) is the most common solid lesion within the kidney and accounts
for most kidney malignancies. The primary tumor size primarily determines the risk of …

To understand the origin of disease comorbidity and to identify the essential proteins and
pathways underlying comorbid diseases, we developed LeMeDISCO (L arge-Scal e M …

Background Sunitinib is a multiple receptor tyrosine kinase inhibitor (TKI) used for the
treatment of renal cell carcinoma (RCC). It increases the median survival considerably with …

Ovarian metastasis is common with secondary tumors representing up to 15% of ovarian
neoplasms. The malignancies most commonly involving the ovaries are carcinomas of the …

A large cell neuroendocrine carcinoma of the ovary is presented because of tubal
metastases with peculiar growth patterns: pagetoid and serous tubal intraepithelial …

Renal cell carcinoma (RCC) accounts for 2–3% of all adult malignancies. Clear-cell type
RCC is the most common type, accounting for approximately 75% of all renal cancer cases …